Condition: Brain Metastases · Sponsor: University Hospital Ostrava
This multicentre proof-of-concept study, involving 4 centers, aims to establish the value of fractionated neoadjuvant stereotactic radiotherapy (NaSRT) as a new treatment paradigm for brain metastases (BM) in the frame of the Czech neurooncology network. Most relevant studies published to date used single-fraction radiotherapy and dealt with the inherent bias related to their retrospective nature. The researchers aim to increase the level of evidence for this treatment paradigm together with other similar ongoing studies.
This description comes directly from the study's public registry record.
Jiří Hynčica · 0042059737 · jiri.hyncica@fno.cz
Always discuss trial participation with your own doctor first.
| University Hospital Ostrava | Ostrava, Moravian-Silesian Region, Czechia | Recruiting |
| Masaryk Memorial Cancer Institute | Brno, Czechia | Recruiting |
| University Hospital Hradec Králové | Hradec Králové, Czechia | Recruiting |
| University Hospital Olomouc | Olomouc, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06933199